लोड हो रहा है...
Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance
The use of direct-acting antivirals (DAAs) to treat chronic hepatitis C has resulted in a significant increase in rates of sustained viral response (around 90%-95%) as compared with the standard treatment of peginterferon/ribavirin. Despite this, however, the rates of therapeutic failure in daily cl...
में बचाया:
| में प्रकाशित: | World J Gastroenterol |
|---|---|
| मुख्य लेखकों: | , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Baishideng Publishing Group Inc
2016
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4970473/ https://ncbi.nlm.nih.gov/pubmed/27547001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i29.6573 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|